In prostate and breast cancer, it is reported that the tumor-supportive effect of fibroblast-derived CXCL14 depends on nitric oxide synthase NOS1 mediated signaling mechanisms [34, 35]. This evidence concerns the gene CXCL14 and breast cancer.